This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Suneva Medical Raises $35 Million In Funding

SAN DIEGO, Jan. 9, 2014 /PRNewswire/ --  Suneva Medical, Inc., a privately-held aesthetics company, announced that it has recently raised $35 million in debt and equity capital. The new capital was structured to be comprised of a growth-capital term loan, a working capital facility, and a Series B equity round financing of $20 million

Polaris Partners led the Series B round, with an affiliate of HealthCare Royalty Partners ("HC Royalty") providing the growth-capital term loan and also participating in the Series B round.  Other existing investors participated in the Series B round, and the working capital facility was provided by Comerica Bank.

The Series B financing includes up-front and product-related milestone investments, and Brian Chee, Managing Partner at Polaris Partners, has joined the Suneva Medical Board of Directors.

"The proven track record of Suneva's management team, coupled with its product distribution partnerships and product portfolio, create a compelling future for the company," said Todd Davis, Founding  Managing Director at HC Royalty and Suneva Board Member. "We are pleased to welcome Brian Chee as a director of the company, and look forward to working with him in assisting the company in pursuit of its vision to be a standout innovator in the aesthetics market."

Nicholas L. Teti, Jr., Chairman and Chief Executive Officer of Suneva Medical, added: "In a short time, we have put Suneva on the path toward success by growing the core business, investing in innovative product research, and working strategically with the right partners. This funding is a vote of confidence in the Suneva team and strategy, giving us the financial platform upon which to execute our vision to build a profitable and dynamic aesthetics company."  

For more information on Suneva Medical, visit www.sunevamedical.com.

Media interested in speaking with a Suneva Medical representative should contact Melody Demel at 619-234-0345 or suneva@formulapr.com.

About HealthCare Royalty PartnersHealthCare Royalty Partners is a global healthcare investment firm that provides financing solutions to healthcare companies and royalty owners with interests in approved pharmaceutical and medical device products. The firm's senior investment team has participated in nearly 50 royalty financings valued at over $2 billion over the past decade. For more information, visit  www.healthcareroyalty.com.  

About Polaris PartnersPolaris Partners is a $3.5B diversified investment firm, focused in Healthcare and Technology. The firm partners with entrepreneurs to bring disruptive ideas to life. Polaris makes investments across all company lifecycle stages and has offices in Boston, San Francisco, and Dublin, Ireland.  For more information, visit www.polarispartners.com 

About Comerica BankComerica Incorporated (NYSE: CMA) is a financial services company headquartered in Dallas, Texas, and strategically aligned by three business segments: The Business Bank, The Retail Bank, and Wealth Management. Comerica focuses on relationships, and helping people and businesses be successful. In addition to Texas, Comerica Bank locations can be found in Arizona, California, Florida and Michigan, with select businesses operating in several other states, as well as in Canada and Mexico. To find Comerica on Facebook, please visit www.facebook.com/ComericaCares. Follow Comerica on Twitter at @ComericaCares and follow Comerica Chief Economist Robert Dye on Twitter at @Comerica_Econ.

About Suneva Medical, Inc.Suneva Medical, Inc. is a privately-held aesthetics company focused on developing, manufacturing and commercializing novel, differentiated products for the general dermatology and aesthetic markets. The company currently markets ArteFill ® in the US, Korea, and Singapore;  ReFissa® and  Regenica® Skincare in the U.S. and Bellafill ® in Canada. For more information, visit  www.sunevamedical.com.

CONTACT: Melody DemelFormula619-234-0345 suneva@formulapr.com

SOURCE Suneva Medical, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,564.26 -119.32 -0.67%
S&P 500 2,052.22 -16.54 -0.80%
NASDAQ 4,921.5770 -70.3630 -1.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs